Source: PRWeb

Press Release: Specific : bioMrieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL Rapid AST system in Europe

bioMérieux, a world leader in the field of in vitro diagnostics, and Specific Diagnostics, a company bringing unique in vitro diagnostic systems to clinical microbiology, announce that bioMérieux will distribute Specific Diagnostics' newly introduced REVEAL Rapid AST system in Europe.(PRWeb June 29, 2021)Read the full story at https://www.prweb.com/releases/biomerieux_and_specific_diagnostics_announce_a_co_exclusive_distribution_agreement_for_the_specific_reveal_rapid_ast_system_in_europe/prweb18040112.htm

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Paul Rhodes's photo - Co-Founder & CEO of Specific

Co-Founder & CEO

Paul Rhodes

CEO Approval Rating

90/100

Read more